Expansion in U.S. Operations
Kodak expanded its U.S. operations in the pharmaceutical and battery sectors, with ongoing investments in AM&C growth initiatives, including a new CGMP pharma manufacturing facility set to be online later this year.
Demand Increase for Film Products
Demand for various types of film, including motion picture and NDT, continues to grow, prompting investments in expanding film facility capacity.
Progress in Commercial Print Business
Transitioned from controlled introduction to controlled production of the PROSPER ULTRA 520 press, with several installations underway at customer sites.
U.S. Manufacturing Commitment
Kodak remains committed to U.S.-based manufacturing, maintaining operations for over 100 years, which reduces environmental impact and ensures high quality.
Pension Plan Update
The termination and settlement process for the U.S. pension plan (KRIP) is proceeding as planned, with potential use of reverted assets to reduce long-term debt.